The South & Central America lithotripsy market was valued at US$ 103.15 million in 2023 and is expected to reach US$ 153.32 million by 2031; it is estimated to register a CAGR of 5.1% from 2023 to 2031.
Mobile lithotripsy medical units, commercial tractor-trailers, and coaches are significantly beneficial to patients. These units offer patients a new healthcare service without any requirement to set up a specialized lithotripsy center or additional investment. Patients' experience with mobile lithotripsy services is significantly improving with technological advancements. For example, in June 2021, Mobile Medical announced launching its new state-of-the-art mobile lithotripsy unit. The lithotripter device was successfully removed from the existing lithotripsy center and installed in a cab/mobile truck. Similarly, The Oklahoma Mobile Lithotripsy Associates (OMLA), a subsidiary of Oklahoma Lithotripter Associates, has continued to provide extracorporeal shockwave lithotripsy (ESWL) services to area hospitals through a lithotripsy bus/trailer since 1995. The service began with a single Dornier unit. However, with a rise in technological advancements, the units are now transported to each location in small vans, making accessibility and scheduling noninvasive lithotripsy procedures much more accessible. Currently, mobile lithotripsy service is only available in developed countries, particularly in the US, and is anticipated to grow in other countries in the future if awareness about mobile lithotripsy service is increased worldwide. Thus, the rise in mobile lithotripsy services is anticipated to create lucrative opportunities for the lithotripsy service providers in the market in the coming years.
The prevalence of nephrolithiasis in Brazil is approximately 5%, with a recurrence rate of 80–90%, as per the Springer 2024 report. According to the National Institute of Health (NIH) report, in Brazil, the prevalence of nephrolithiasis has increased in the past decade, which has had a massive impact on the healthcare system with limited lithotripsy procedures. For example, the frequency of performing percutaneous nephrolithotomy (PCNL) by urologists in Brazil is less compared to other ureteroscopies as the procedure can lead to various complications such as sepsis, injury to adjacent organs, and hemorrhage and death. ESWL is a noninvasive technique having minimal complications therefore, with increase in adoption of ESWL in the Brazilian hospitals in the coming years, it will surpass the traditional PCNL techniques.
The South & Central America lithotripsy market is categorized into product type, application, end user, and country.
By product type, the South & Central America lithotripsy market is segmented into extracorporeal shock wave lithotripsy devices, intracorporeal lithotripsy devices, and ureteroscopic. The extracorporeal shock wave lithotripsy devices segment held the largest share of the South & Central America lithotripsy market share in 2023.
In term of application, the South & Central America lithotripsy market is segmented into kidney stones, ureteral stones, pancreatic stones, bile duct stones, and bladder stones. The kidney stones segment held the largest share of the South & Central America lithotripsy market share in 2023.
Based on end-user, the South & Central America lithotripsy market is segmented into hospitals, specialty clinics, and others. The hospitals segment held the largest share of the South & Central America lithotripsy market share in 2023.
Based on country, the South & Central America lithotripsy market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil segment held the largest share of South & Central America lithotripsy market in 2023.
Becton Dickinson and Co, Boston Scientific Corp, DirexGroup, Edap Tms SA, ELMED Medical Systems, EMS Electro Medical Systems SA (EMS+), Karl Storz SE & Co KG, NOVAmedtk, Olympus Corp, and Potent Medical are some of the leading companies operating in the South & Central America lithotripsy market.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 103.15 Million |
| Market Size by 2031 | US$ 153.32 Million |
| CAGR (2023 - 2031) | 5.1% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered |
South & Central America
|
| Market leaders and key company profiles |
|
The South & Central America Lithotripsy Market is valued at US$ 103.15 Million in 2023, it is projected to reach US$ 153.32 Million by 2031.
As per our report South & Central America Lithotripsy Market, the market size is valued at US$ 103.15 Million in 2023, projecting it to reach US$ 153.32 Million by 2031. This translates to a CAGR of approximately 5.1% during the forecast period.
The South & Central America Lithotripsy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Lithotripsy Market report:
The South & Central America Lithotripsy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Lithotripsy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Lithotripsy Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)